HealthMore in Health→
Biotech Investors Are Starting to Chase New Bets Again
Key Takeaways
- Biotech VCs are showing more appetite for new deals.
- The shift follows years of focusing on existing portfolios.
- A return to first checks could widen the startup pipeline again.
DE
DT Editorial Team··via endpoints.news
